Access to DNA sequence information on a genomic scale has enabled the design of ever-larger sets of oligonucleotides (oligos) for a wide variety of high-throughput assays. The ability to go directly from sequence information to synthetic oligos has been a cornerstone of many key advances in genomics. However, although the cost of oligo synthesis has decreased dramatically, it is still too expensive for many applications. We propose to address this major need in genomics. This Phase I proposal aims to develop a novel, inexpensive, highly flexible and efficient approach for manufacturing oligos. It is applicable to a wide range of applications in genomics. Synthetic DNA is used in a wide variety of assays to decode the genome. This proposal aims to develop new, highly efficient ways of making and using synthetic DNA. This will broaden the reach of genomics and its application to advances in medicine. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Human Genome Research Institute (NHGRI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43HG004284-01
Application #
7272629
Study Section
Special Emphasis Panel (ZRG1-GGG-J (10))
Program Officer
Ozenberger, Bradley
Project Start
2007-05-21
Project End
2008-05-20
Budget Start
2007-05-21
Budget End
2008-05-20
Support Year
1
Fiscal Year
2007
Total Cost
$195,018
Indirect Cost
Name
Prognosys Biosciences, Inc.
Department
Type
DUNS #
170943737
City
San Diego
State
CA
Country
United States
Zip Code
92121
Kozlov, Igor A; Thomsen, Elliot R; Munchel, Sarah E et al. (2012) A highly scalable peptide-based assay system for proteomics. PLoS One 7:e37441